Michael Dickinson, MBBS, DMedSc, on Glofitamab Combination Trials Underway

By Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA - January 19, 2023

Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA, of the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, discusses trials in progress that are evaluating glofitamab, a bispecific antibody, in combination with other agents for the treatment of diffuse large B-cell lymphoma.

Advertisement
Editorial Board

Advertisement